Isracann Biosciences Inc.
Isracann Biosciences Inc. (ISCNF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
iscnf · pe ratio · data through May 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Isracann Biosciences Inc. (ISCNF) measures how much investors pay for each dollar of the company's trailing earnings. ISCNF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.03.
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-05-31
PE Ratio History
2011 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Isracann Biosciences Inc.You ISCNF | $0M | N/A | — | -$0.03 |
 Avicanna Inc. AVCNF | $10M | N/A | — | -$0.02 |
 INDVR Brands Inc. CAAOF | $0M | N/A | — | -$0.06 |
 Choom Holdings Inc. CHOOF | $0M | N/A | — | -$0.07 |
 Charlotte's Web Holdings, Inc. CWBHF | $67M | N/A | — | -$0.19 |
 Molecule Holdings Inc. EVRRF | $1M | N/A | — | -$0.05 |
 Global Pharmatech, Inc. GBLP | $29M | N/A | — | -$0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-05-31Latest FY2022 | — | $-0.03 | — | |
2021-05-31 FY2021 | — | $-0.18 | — | |
2020-05-31 FY2020 | — | $-0.26 | — | |
2019-05-31 FY2019 | — | $-0.75 | — | |
2018-05-31 FY2018 | — | $-0.33 | — | |
2017-05-31 FY2017 | — | $-0.12 | — | |
2016-05-31 FY2016 | — | $-0.09 | — | |
2015-05-31 FY2015 | — | $-0.15 | — | |
2014-05-31 FY2014 | — | $-0.04 | — | |
2013-05-31 FY2013 | — | $-0.04 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Isracann Biosciences Inc. (ISCNF) measures how much investors pay for each dollar of the company's trailing earnings. ISCNF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.03.
Frequently asked questions
ISCNF pe ratio · 6 questionsISCNF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.03. Data sourced from Financial Modeling Prep via ISCNF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Isracann Biosciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09